Linus Health, a Boston, MA-based digital health company focused on improving brain health, raised $55m in Series B funding.
The backers were not disclosed.
The company intends to use the funds to grow its team and accelerate development of its platform.
Led by David Bates, CEO, and Alvaro Pascual-Leone, co-founder, and a behavioral neurologist, neuroscientist, and Professor of Neurology at Harvard Medical School, Linus deploys technologies to promote overall health and mental acuity. Linus’s multimodal, smartphone- or tablet-based brain health solution collects objective data from multiple digital measures of cognitive and motor function (“digital biomarkers”) and translates this data into actionable insights. The solution allows care professionals to monitor brain health remotely, easily and conveniently over extended periods of time, even outside of clinical settings. Linus collects, aggregates and analyzes information drawn from data points like voice and speech patterns, visuospatial memory, dual-tasking ability and fine motor control, as well as movement, balance, and pulmonary capacity and can link with electronic health records to provide a comprehensive picture of individuals’ brain health.
Researchers have used the platform and assessments, such as the DCTclock™ digital clock-drawing test, to identify the beginnings of Alzheimer’s disease pathology in their studies.
BIGfish Communications for Linus Health